Evidence map›Paper›PMID 24487386›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2014

IL-1β induction of MUC5AC gene expression is mediated by CREB and NF-κB and repressed by dexamethasone.

Yajun Chen, Lindsay M Garvin, Tracey J Nickola, Alan M Watson, Anamaris M Colberg-Poley, Mary C Rose

2 registry-linked trialsAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03513458 phase1 / phase2withdrawnnot on this mapstarted 2020, after this paper: background citation

Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2020 to 2021Enrolled0ConditionsAsthmaArmsAnakinra, Anakinra Matching Placebo, Dermatophagoides Farinae
NCT03513471 phase1 / phase2withdrawnnot on this mapstarted 2019, after this paper: background citation

Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2021Enrolled0ConditionsAsthmaArmsAnakinra, Anakinra Matching Placebo, Dermatophagoides Farinae
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 75 citations in OpenAlex.

  1. Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery.Journal of the American Society of Nephrology : JASN · 2015
    Trial
  2. Epigenetic regulation and chromatin organization in cystic fibrosis airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Review
  3. Mucins and Respiratory Virus Infection.Annual review of virology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Mucins and Their Roles in Asthma.Immunological reviews · 2025
    Review
  8. Dipeptidyl peptidase-1 inhibitors in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. IL-1β Promotes Expansion of IL-33American journal of respiratory cell and molecular biology · 2022
    Article
  17. Frontiers in cellular and infection microbiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yajun ChenChildren's National, 111 Michigan Ave NW, Washington, DC 20010. mrose@childrensnational.org.
Lindsay M Garvin
Tracey J Nickola
Alan M Watson
Anamaris M Colberg-Poley
Mary C Rose
Children's National · USGeorge Washington University · US

Funding

NHLBI NIH HHS HL-33052
6 · The paper itself

Abstract

Chronic airway diseases are characterized by inflammation and mucus overproduction. The MUC5AC mucin gene is upregulated by the proinflammatory cytokine interleukin-1 β (IL-1β) via activation of cAMP response element-binding protein (CREB) in the NCI-H292 cancer cell line and nuclear factor-κB (NF-κB) in the HBE1 transformed cell line, with each transcription factor binding to a cognate cis site in the proximal or distal region, respectively, of the MUC5AC promoter. We utilized primary differentiated human bronchial epithelial (HBE) and A549 lung adenocarcinoma cells to further investigate the contributions of CREB and NF-κB subunits to the IL-1β-induced upregulation of MUC5AC. Data show that ligand binding of IL-1β to the IL-1β receptor is required to increase MUC5AC mRNA abundance. Chromatin immunoprecipitation analyses show direct binding of CREB to the previously identified cAMP response element site and binding of p65 and p50 subunits to a novel NF-κB site in a mucin-regulatory domain in the proximal promoter and to a previously identified NF-κB site in the distal promoter. P50 binds to both NF-κB sites at 1 h following IL-1β exposure, but is replaced at 2 h by p65 in A549 cells and by a p50/p65 heterodimer in HBE cells. Thus IL-1β activates multiple domains in the MUC5AC promoter but exhibits some cell-specific responses, highlighting the complexity of MUC5AC transcriptional regulation. Data show that dexamethasone, a glucocorticoid that transcriptionally represses MUC5AC gene expression under constitutive conditions, also represses IL-1β-mediated upregulation of MUC5AC gene expression. A further understanding of mechanisms mediating MUC5AC regulation should lead to a honing of therapeutic approaches for the treatment of mucus overproduction in inflammatory lung diseases.

Indexed as

Gene Expression RegulationAdenocarcinomaAnti-Inflammatory AgentsBronchiCells, CulturedChromatin ImmunoprecipitationCyclic AMP Response Element-Binding ProteinDexamethasoneDNA-Directed RNA PolymerasesElectrophoretic Mobility Shift AssayHumansInterleukin-1betaLung NeoplasmsMucin 5ACNF-kappa BPromoter Regions, GeneticAnti-Inflammatory AgentsCREB1 protein, humanCyclic AMP Response Element-Binding ProteinDexamethasoneDNA-Directed RNA PolymerasesInterleukin-1betaMUC5AC protein, humanMucin 5ACNF-kappa BReceptors, Interleukin-1RNA, Messengerchronic inflammatory lung diseasedexamethasonegene regulationIL-1βinflammatory transcription factorsMUC5AC mucin

Identifiers

PMID24487386
PMCPMC3989721
OpenAlexW2170397771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.